You have no items in your shopping cart.
Search results for: 'IL-21'
- Featured
Featured
Greater than 85% as determined by SDS-PAGE.
22.5 kDa
E.coli
Homo sapiens (Human)
30-162aa
Partial
C-terminal 6xHis-tagged
1 mg, 100 μg, 20 μg SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 16.5 KDa. Observed: 16 KDa, reducing conditions
Pro25-Ser146
N-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.6 KDa. Observed: 16 KDa, reducing conditions
Gln30-Ser162
Tag free
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.4 KDa. Observed: 16 KDa, reducing conditions
Pro25-Ser146
Tag free
10 μg, 50 μg, 500 μg, 1 mg>97% by SDS-PAGE and HPLC analyses.
Approximately 15.4 kDa, a single non-glycosylated polypeptide chain containing 132 amino acids.
Escherichia coli.
2 μg, 10 μg, 1 mg- RecombinantIL-21,Mouse [orb1494824]
> 95% as analyzed by SDS-PAGE.
15.1 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 10 μg, 50 μg - RecombinantIL-21,Human [orb1494825]
> 95% by SDS-PAGE analysis.
15.4 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 10 μg, 50 μg >95% by SDS-PAGE and HPLC analyses.
Approximately 15.2 kDa, a single non-glycosylated polypeptide chain containing 129 amino acids.
Escherichia coli.
2 μg, 10 μg, 1 mg

